Optimizing regional therapy for melanoma

Georgia M. Beasley; Douglas S. Tyler

doi:10.1245/s10434-009-0329-4

Optimizing regional therapy for melanoma

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	1095-1097
Number of pages	3
Journal	Annals of surgical oncology
Volume	16
Issue number	5
DOIs	https://doi.org/10.1245/s10434-009-0329-4
State	Published - May 2009
Externally published	Yes

ASJC Scopus subject areas

Surgery
Oncology

Access to Document

10.1245/s10434-009-0329-4

Cite this

@article{cbbb09397893435cafe49b3ee85f3b0b,

title = "Optimizing regional therapy for melanoma",

author = "Beasley, {Georgia M.} and Tyler, {Douglas S.}",

note = "Funding Information: ACKNOWLEDGEMENTS Dr. Tyler is co-inventor on a patent entitled {\textquoteleft}{\textquoteleft}Cancer treatment methods using cadherin antagonists in combination with anticancer agents.{\textquoteright}{\textquoteright} The patent application number is 60/848,624 and this patent was filed on 9/27/06. Dr. Tyler has signed over all rights to the patent to the Federal Government. Dr. Tyler has received some research funding from Adherex Technologies Inc. for his laboratory. Dr. Tyler also has material transfer agreements with Schering, Genta, Inotek, and Bayer to provide his laboratory with reagents to study. Dr. Tyler does not receive grant support from these companies.",

year = "2009",

month = may,

doi = "10.1245/s10434-009-0329-4",

language = "English (US)",

volume = "16",

pages = "1095--1097",

journal = "Annals of surgical oncology",

issn = "1068-9265",

publisher = "Springer New York",

number = "5",

}

TY - JOUR

T1 - Optimizing regional therapy for melanoma

AU - Beasley, Georgia M.

AU - Tyler, Douglas S.

N1 - Funding Information: ACKNOWLEDGEMENTS Dr. Tyler is co-inventor on a patent entitled ‘‘Cancer treatment methods using cadherin antagonists in combination with anticancer agents.’’ The patent application number is 60/848,624 and this patent was filed on 9/27/06. Dr. Tyler has signed over all rights to the patent to the Federal Government. Dr. Tyler has received some research funding from Adherex Technologies Inc. for his laboratory. Dr. Tyler also has material transfer agreements with Schering, Genta, Inotek, and Bayer to provide his laboratory with reagents to study. Dr. Tyler does not receive grant support from these companies.

PY - 2009/5

Y1 - 2009/5

UR - http://www.scopus.com/inward/record.url?scp=64249112078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64249112078&partnerID=8YFLogxK

U2 - 10.1245/s10434-009-0329-4

DO - 10.1245/s10434-009-0329-4

M3 - Review article

C2 - 19189189

AN - SCOPUS:64249112078

SN - 1068-9265

VL - 16

SP - 1095

EP - 1097

JO - Annals of surgical oncology

JF - Annals of surgical oncology

IS - 5

ER -

Optimizing regional therapy for melanoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this